ÂÜÀòÂÒÂ×

Inge Van Dooren is an accomplished professional with extensive experience in the pharmaceutical industry, currently serving as the Director of Technical Operations for Advanced Therapies at Johnson & Johnson since July 2010, focusing on new product introduction in cell and gene therapies. Prior to this role, Inge held various positions at Janssen Pharmaceutica, including Director of Product Quality, Senior Manager of Product Quality Management, and QA Manager for Aseptic Processing, contributing to the quality assurance of sterile and transdermal products from 2001 to 2010. Inge's educational background includes a Master’s degree in engineering with a specialization in microbiology from KU Leuven, completed between 1993 and 1998.